Description: FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.
Home Page: www.fibrobiologics.com
455 East Medical Center Boulevard
Houston,
TX
77598
United States
Phone:
281 651 5150
Officers
| Name | Title |
|---|---|
| Mr. Peter O'Heeron | Founder, Chairperson & CEO |
| Mr. Robert E. Hoffman B.B.A., CPA | Interim CFO & Director |
| Dr. Hamid Khoja Ph.D. | Chief Scientific Officer |
| Mr. Ruben A. Garcia J.D. | General Counsel |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 28.7454 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2024-01-31 |
| Fiscal Year End: | June |
| Full Time Employees: | 10 |